Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Rapid decrease of serum endothelin-1 levels after treatment with ACE inhibitors in chronic cardiac failure]

E Ferrari¹, E Drai, D Jambou

¹Service de cardiologie, hôpital Pasteur, Nice.

Archives Des Maladies Du Coeur Et Des Vaisseaux

|September 28, 1998

Summary

Angiotensin converting enzyme (ACE) inhibitor therapy significantly reduced elevated plasma endothelin-1 levels in patients with severe cardiac failure within 72 hours. This finding may explain some beneficial effects of ACE inhibitors in heart failure patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.

International journal of laboratory hematology·2016

Same author

AA genotype of single-nucleotide polymorphism c.834+7G>A in GAS6 gene (rs8191974) is not protective for acute myocardial infarction.

International journal of laboratory hematology·2013

Same author

Measurement of factor VIII activity using one-stage clotting assay: a calibration curve has not to be systematically included in each run.

Haemophilia : the official journal of the World Federation of Hemophilia·2010

Same author

[Local registry of pacemakers implantations: proposals to decrease the infectious risk].

Annales de cardiologie et d'angeiologie·2006

Same author

[Repeated thromboembolism during pregnancy with constitutional antithrombin deficiency].

Journal de gynecologie, obstetrique et biologie de la reproduction·2004

Same author

An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2003

Area of Science:

Cardiovascular Medicine
Endocrinology
Pharmacology

Context:

Circulating endothelin-1 is elevated in cardiac failure, contributing to adverse effects.
The impact of common medications on endothelin-1 levels in heart failure is not well understood.
Endothelin-1 is a potent vasoconstrictor peptide implicated in cardiovascular disease.

Purpose:

To investigate the effect of angiotensin converting enzyme (ACE) inhibitor therapy on plasma endothelin-1 levels in patients with severe cardiac failure.
To determine if ACE inhibitors can modulate endothelin-1, a key factor in cardiac dysfunction.

Summary:

Plasma endothelin-1 levels were measured in 24 patients with NYHA class III-IV cardiac failure before and after treatment with Captopril (an ACE inhibitor).
A control group of 10 patients was monitored to account for environmental factors.

Related Experiment Videos

ACE inhibitor therapy led to a significant decrease in plasma endothelin-1 levels within 72 hours (p < 0.02), though levels remained elevated compared to normal.

Impact:

ACE inhibitor therapy demonstrates a rapid reduction in plasma endothelin-1 levels in severe cardiac failure.
This reduction may contribute to the known therapeutic benefits of ACE inhibitors in managing heart failure.
The findings support experimental data and suggest a mechanism for ACE inhibitor efficacy in cardiovascular conditions.